The appointment of Grayson establishes the independence of the Board of Directors and expands the current Board of Directors to four membersIRVINE, Calif., October...
Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...